# TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation

> **NCT03833479** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Grupo Español de Investigación en Cáncer de Ovario** · enrollment: 134 (actual)

## Conditions studied

- Cervical Cancer
- Advanced Cancer

## Interventions

- **OTHER:** No Further Treatment
- **DRUG:** TSR-042

## Key facts

- **NCT ID:** NCT03833479
- **Lead sponsor:** Grupo Español de Investigación en Cáncer de Ovario
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-06-28
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2025-05-21

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03833479

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03833479, "TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03833479. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*